Giuseppe Campolongo

520 total citations
16 papers, 338 citations indexed

About

Giuseppe Campolongo is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giuseppe Campolongo has authored 16 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giuseppe Campolongo's work include Lipoproteins and Cardiovascular Health (6 papers), Aortic Disease and Treatment Approaches (3 papers) and Microbial Metabolism and Applications (3 papers). Giuseppe Campolongo is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Aortic Disease and Treatment Approaches (3 papers) and Microbial Metabolism and Applications (3 papers). Giuseppe Campolongo collaborates with scholars based in Italy, Slovenia and United States. Giuseppe Campolongo's co-authors include Maurizio Volterrani, Giuseppe Marazzi, Luca Cacciotti, Michele Vitacca, Palmira Bernocchi, Barbara Sposato, Doriana Baratti, Mara Paneroni, Maria Teresa La Rovere and Simonetta Scalvini and has published in prestigious journals such as Circulation, The American Journal of Cardiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Giuseppe Campolongo

16 papers receiving 332 citations

Peers

Giuseppe Campolongo
Michael F. Caron United States
Aileen B Luzier United States
Jacqueline Honerlaw United States
Pratik Rane United States
Giuseppe Campolongo
Citations per year, relative to Giuseppe Campolongo Giuseppe Campolongo (= 1×) peers Joey S.W. Kwong

Countries citing papers authored by Giuseppe Campolongo

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Campolongo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Campolongo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Campolongo more than expected).

Fields of papers citing papers by Giuseppe Campolongo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Campolongo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Campolongo. The network helps show where Giuseppe Campolongo may publish in the future.

Co-authorship network of co-authors of Giuseppe Campolongo

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Campolongo. A scholar is included among the top collaborators of Giuseppe Campolongo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Campolongo. Giuseppe Campolongo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Marazzi, Giuseppe, Giuseppe Caminiti, Marco Alfonso Perrone, et al.. (2024). Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study. Journal of Cardiovascular Development and Disease. 11(9). 286–286. 1 indexed citations
2.
Mone, Pasquale, Raffaele Izzo, Giuseppe Marazzi, et al.. (2022). L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic. Journal of Pharmacology and Experimental Therapeutics. 381(3). 197–203. 17 indexed citations
3.
Marazzi, Giuseppe, Giuseppe Campolongo, Francesco Pelliccia, et al.. (2018). Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment. The American Journal of Cardiology. 123(2). 233–238. 15 indexed citations
4.
Marazzi, Giuseppe, Giuseppe Campolongo, Francesco Pelliccia, et al.. (2018). BISOPROLOL BETTER THAN ATENOLOL AS ADD ON THERAPY TO ACE INHIBITORS IN BLOOD PRESSURE CONTROL. Journal of Hypertension. 36(Supplement 1). e43–e43. 3 indexed citations
5.
Marazzi, Giuseppe, Giuseppe Campolongo, Francesco Pelliccia, et al.. (2017). Comparison of Low-Dose Statin Versus Low-Dose Statin + Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial). The American Journal of Cardiology. 120(6). 893–897. 22 indexed citations
6.
Bernocchi, Palmira, Michele Vitacca, Maria Teresa La Rovere, et al.. (2017). Home-based telerehabilitation in older patients with chronic obstructive pulmonary disease and heart failure: a randomised controlled trial. Age and Ageing. 47(1). 82–88. 120 indexed citations
7.
Marazzi, Giuseppe, Francesco Pelliccia, Giuseppe Campolongo, et al.. (2016). Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial. International Journal of Cardiology. 222. 885–887. 10 indexed citations
8.
Campolongo, Giuseppe, Valeria Raparelli, Ilaria Spoletini, et al.. (2016). The combination of nutraceutical and simvastatin enhances the effect of simvastatin alone in normalising lipid profile without side effects in patients with ischemic heart disease. INFM-OAR (INFN Catania). 11. 3–6. 10 indexed citations
9.
Cangemi, Roberto, Giulio Francesco Romiti, Giuseppe Campolongo, et al.. (2016). Gender related differences in treatment and response to statins in primary and secondary cardiovascular prevention: The never-ending debate. Pharmacological Research. 117. 148–155. 52 indexed citations
10.
Marazzi, Giuseppe, Francesco Pelliccia, Giuseppe Campolongo, et al.. (2015). Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease. The American Journal of Cardiology. 116(12). 1798–1801. 31 indexed citations
11.
Pelliccia, Francesco, Giuseppe Campolongo, Rosalba Massaro, et al.. (2015). Ranolazine reduces symptoms of palpitations and documented arrhythmias in patients with ischemic heart disease — The RYPPLE randomized cross-over trial. INFM-OAR (INFN Catania). 7. 8–8. 4 indexed citations
12.
Cacciotti, Luca, Ilaria Passaseo, Giuseppe Marazzi, et al.. (2012). Observational study on Takotsubo-like cardiomyopathy: clinical features, diagnosis, prognosis and follow-up. BMJ Open. 2(5). e001165–e001165. 40 indexed citations
13.
Greco, Cesare, et al.. (2008). Transnasal transesophageal echocardiography: A new approach for the PFO occlusion in awake patients. Catheterization and Cardiovascular Interventions. 72(4). 538–541. 7 indexed citations
14.
Mollo, Pasquale, et al.. (2006). Transesophageal Echocardiography Through Nasal Way as a Guide to Percutaneous Closure of Patent Foramen Ovale. Echocardiography. 23(9). 790–792. 2 indexed citations
15.
Campolongo, Giuseppe, et al.. (2005). Transesophageal Echocardiography Through Nasal Way Diagnoses Bicuspid Aortic Valve. Echocardiography. 22(2). 149–150. 1 indexed citations
16.
Mollo, Pasquale, et al.. (2005). Left Ventricular Pseudoaneurysm. Circulation. 111(4). e35–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026